Article
<i>Ex vivo</i> therapeutic base and prime editing using chemically derived hepatic progenitors in a mouse model of tyrosinemia type 1
2020-09-15
Abstract excerpt
<h4>Summary</h4> DNA base editors and prime editing technology capable of therapeutic base conversion enable ex vivo gene editing therapy for various genetic diseases. For such therapy, it is critical that the target cells survive well both outside the body and after transplantation. In this regard, chemically derived stem/progenitor cells are attracting attention as the most useful cell sources for clinical tri...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c378b658-60c3-5c76-8c0e-0ab4a78d1e47
- DOI
- 10.1101/2020.09.14.297275
